| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 9.64e-06 | 14 | 61 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 5.49e-05 | 4 | 61 | 2 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 5.49e-05 | 4 | 61 | 2 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 5.49e-05 | 4 | 61 | 2 | GO:0047743 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 7.53e-05 | 27 | 61 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 9.13e-05 | 5 | 61 | 2 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 9.13e-05 | 5 | 61 | 2 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 9.13e-05 | 5 | 61 | 2 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 9.13e-05 | 5 | 61 | 2 | GO:0047006 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 9.13e-05 | 5 | 61 | 2 | GO:0047787 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 9.13e-05 | 5 | 61 | 2 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 9.13e-05 | 5 | 61 | 2 | GO:0047086 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 1.26e-04 | 32 | 61 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.37e-04 | 6 | 61 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.91e-04 | 7 | 61 | 2 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.54e-04 | 8 | 61 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 2.54e-04 | 8 | 61 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 2.54e-04 | 8 | 61 | 2 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 3.26e-04 | 9 | 61 | 2 | GO:0047044 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 3.26e-04 | 9 | 61 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | NADP+ binding | 3.26e-04 | 9 | 61 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 4.07e-04 | 10 | 61 | 2 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 4.07e-04 | 10 | 61 | 2 | GO:0032052 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 4.25e-04 | 48 | 61 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 4.96e-04 | 11 | 61 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 6.70e-04 | 56 | 61 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 8.16e-04 | 14 | 61 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.61e-03 | 279 | 61 | 5 | GO:0005096 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.68e-03 | 20 | 61 | 2 | GO:0004303 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 2.43e-03 | 24 | 61 | 2 | GO:0030742 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 2.43e-03 | 24 | 61 | 2 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.85e-03 | 26 | 61 | 2 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 2.85e-03 | 26 | 61 | 2 | GO:0070402 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.69e-03 | 207 | 61 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.75e-03 | 208 | 61 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 3.78e-03 | 30 | 61 | 2 | GO:0018455 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 4.30e-03 | 107 | 61 | 3 | GO:0033293 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 4.44e-03 | 507 | 61 | 6 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 4.44e-03 | 507 | 61 | 6 | GO:0030695 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.56e-03 | 33 | 61 | 2 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4.84e-03 | 34 | 61 | 2 | GO:0016628 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 6.13e-03 | 239 | 61 | 4 | GO:0031406 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 6.33e-03 | 39 | 61 | 2 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 6.65e-03 | 40 | 61 | 2 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 6.91e-03 | 127 | 61 | 3 | GO:0016616 | |
| GeneOntologyMolecularFunction | organic acid binding | 7.57e-03 | 254 | 61 | 4 | GO:0043177 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 7.60e-03 | 1356 | 61 | 10 | GO:0060090 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 8.29e-03 | 1160 | 61 | 9 | GO:0030674 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 4.97e-05 | 4 | 60 | 2 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 4.97e-05 | 4 | 60 | 2 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 4.97e-05 | 4 | 60 | 2 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 4.97e-05 | 4 | 60 | 2 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 8.27e-05 | 5 | 60 | 2 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 8.27e-05 | 5 | 60 | 2 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 8.27e-05 | 5 | 60 | 2 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 8.27e-05 | 5 | 60 | 2 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 8.27e-05 | 5 | 60 | 2 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 8.27e-05 | 5 | 60 | 2 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.24e-04 | 6 | 60 | 2 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.24e-04 | 6 | 60 | 2 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 1.73e-04 | 7 | 60 | 2 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 1.73e-04 | 7 | 60 | 2 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 1.73e-04 | 7 | 60 | 2 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 2.96e-04 | 9 | 60 | 2 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 3.69e-04 | 10 | 60 | 2 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 3.69e-04 | 10 | 60 | 2 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 3.69e-04 | 10 | 60 | 2 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 3.69e-04 | 10 | 60 | 2 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 3.69e-04 | 10 | 60 | 2 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 4.50e-04 | 11 | 60 | 2 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 4.50e-04 | 11 | 60 | 2 | GO:0016115 | |
| GeneOntologyBiologicalProcess | protein monoubiquitination | 5.22e-04 | 54 | 60 | 3 | GO:0006513 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 7.40e-04 | 14 | 60 | 2 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 7.40e-04 | 14 | 60 | 2 | GO:0008300 | |
| Domain | ALDOKETO_REDUCTASE_1 | 3.72e-06 | 10 | 60 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 3.72e-06 | 10 | 60 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 3.72e-06 | 10 | 60 | 3 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 3.72e-06 | 10 | 60 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 3.72e-06 | 10 | 60 | 3 | PS00063 | |
| Domain | - | 1.71e-05 | 16 | 60 | 3 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 2.08e-05 | 17 | 60 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 2.08e-05 | 17 | 60 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 2.08e-05 | 17 | 60 | 3 | IPR001395 | |
| Domain | ZINC_FINGER_C2H2_2 | 7.71e-04 | 775 | 60 | 9 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 7.85e-04 | 777 | 60 | 9 | PS00028 | |
| Domain | Znf_C2H2-like | 9.32e-04 | 796 | 60 | 9 | IPR015880 | |
| Domain | Znf_C2H2 | 1.01e-03 | 805 | 60 | 9 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.04e-03 | 808 | 60 | 9 | SM00355 | |
| Domain | ZZ | 1.50e-03 | 18 | 60 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.50e-03 | 18 | 60 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.50e-03 | 18 | 60 | 2 | PS01357 | |
| Domain | Znf_ZZ | 1.68e-03 | 19 | 60 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.68e-03 | 19 | 60 | 2 | SM00291 | |
| Domain | Rho_GTPase_activation_prot | 2.85e-03 | 88 | 60 | 3 | IPR008936 | |
| Domain | - | 4.40e-03 | 207 | 60 | 4 | 1.25.40.10 | |
| Domain | - | 5.91e-03 | 679 | 60 | 7 | 3.30.160.60 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 6.64e-03 | 694 | 60 | 7 | IPR013087 | |
| Domain | TPR-like_helical_dom | 6.67e-03 | 233 | 60 | 4 | IPR011990 | |
| Pathway | REACTOME_PREDNISONE_ADME | 5.50e-05 | 23 | 46 | 3 | MM16639 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 1.04e-04 | 5 | 46 | 2 | MM15582 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 3.70e-04 | 9 | 46 | 2 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 3.70e-04 | 9 | 46 | 2 | M47817 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 3.92e-04 | 44 | 46 | 3 | M499 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 4.19e-04 | 45 | 46 | 3 | MM14751 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 5.62e-04 | 11 | 46 | 2 | M47812 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 7.43e-04 | 126 | 46 | 4 | MM15553 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 7.94e-04 | 13 | 46 | 2 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 7.94e-04 | 13 | 46 | 2 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 9.25e-04 | 14 | 46 | 2 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 9.25e-04 | 14 | 46 | 2 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 9.25e-04 | 14 | 46 | 2 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 9.25e-04 | 14 | 46 | 2 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.06e-03 | 15 | 46 | 2 | MM14870 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 12562828 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 7650035 | ||
| Pubmed | Neutrophils Turn Plasma Proteins into Weapons against HIV-1. | 3.13e-06 | 2 | 62 | 2 | 23840401 | |
| Pubmed | Affinity, kinetics, and thermodynamics of E-selectin binding to E-selectin ligand-1. | 3.13e-06 | 2 | 62 | 2 | 11404363 | |
| Pubmed | 6.02e-06 | 20 | 62 | 3 | 23636947 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 7626489 | ||
| Pubmed | 1.21e-05 | 25 | 62 | 3 | 26098214 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 1.87e-05 | 4 | 62 | 2 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 1.87e-05 | 4 | 62 | 2 | 16508162 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 1.87e-05 | 4 | 62 | 2 | 14967952 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 1.87e-05 | 4 | 62 | 2 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 1.87e-05 | 4 | 62 | 2 | 31479646 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 17442598 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 15222881 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 16191478 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 15577209 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 10702227 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 17034817 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 1.87e-05 | 4 | 62 | 2 | 29764944 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 10526179 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 17888864 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 17442338 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 28329705 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 16018803 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 17272929 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 1.87e-05 | 4 | 62 | 2 | 18667791 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 28259989 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 21521174 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 8274401 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 16511129 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 1.87e-05 | 4 | 62 | 2 | 34590152 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 7789999 | ||
| Pubmed | GAPVD1 ANK3 AP1G1 GLG1 SREBF2 MASTL HIPK2 AKR1C3 AKR1C4 NCOA4 | 2.05e-05 | 1084 | 62 | 10 | 11544199 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 2.84e-05 | 495 | 62 | 7 | 27705803 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 7737980 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 12536145 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 3.12e-05 | 5 | 62 | 2 | 21851338 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 22021370 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 23408908 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 3.12e-05 | 5 | 62 | 2 | 17064890 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 10672042 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 38788959 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 3.12e-05 | 5 | 62 | 2 | 16984997 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 18003893 | ||
| Pubmed | 4.01e-05 | 37 | 62 | 3 | 21362171 | ||
| Pubmed | 4.35e-05 | 38 | 62 | 3 | 1683707 | ||
| Pubmed | Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. | 4.67e-05 | 6 | 62 | 2 | 7511063 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 4.67e-05 | 6 | 62 | 2 | 29107092 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 15299027 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 19273550 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 15860270 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 15471942 | ||
| Pubmed | Lymphotactin: a cytokine that represents a new class of chemokine. | 4.67e-05 | 6 | 62 | 2 | 7973732 | |
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 4.67e-05 | 6 | 62 | 2 | 26748576 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 4.67e-05 | 6 | 62 | 2 | 17255200 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 21169563 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 6.53e-05 | 7 | 62 | 2 | 34843575 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 22529366 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 33127481 | ||
| Pubmed | PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. | 6.53e-05 | 7 | 62 | 2 | 18809579 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 1694218 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 16337335 | ||
| Pubmed | 8.27e-05 | 47 | 62 | 3 | 11208732 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.38e-05 | 588 | 62 | 7 | 38580884 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 29408378 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 33584538 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 19725050 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 20837989 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 9224647 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 9.08e-05 | 807 | 62 | 8 | 30575818 | |
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 24973710 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 33348080 | ||
| Pubmed | The F-box protein Fbl10 is a novel transcriptional repressor of c-Jun. | 1.12e-04 | 9 | 62 | 2 | 17704768 | |
| Pubmed | 1.12e-04 | 52 | 62 | 3 | 23260145 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 1.39e-04 | 10 | 62 | 2 | 36313771 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 18765672 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 26976604 | ||
| Pubmed | Symmetrical modularity of the COP9 signalosome complex suggests its multifunctionality. | 1.39e-04 | 10 | 62 | 2 | 19141280 | |
| Pubmed | The minimal deneddylase core of the COP9 signalosome excludes the Csn6 MPN- domain. | 1.39e-04 | 10 | 62 | 2 | 22956996 | |
| Pubmed | 1.53e-04 | 451 | 62 | 6 | 36168627 | ||
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 10995443 | ||
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 20399188 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 2.04e-04 | 12 | 62 | 2 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 2.04e-04 | 12 | 62 | 2 | 28893949 | |
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 25774556 | ||
| Pubmed | 2.16e-04 | 686 | 62 | 7 | 29987050 | ||
| Pubmed | 2.30e-04 | 167 | 62 | 4 | 25659891 | ||
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 11682476 | ||
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 29507620 | ||
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 17062636 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 2.41e-04 | 13 | 62 | 2 | 15117747 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 7.06e-06 | 90 | 62 | 4 | chr10p15 | |
| Cytoband | 10p15.1 | 6.63e-04 | 28 | 62 | 2 | 10p15.1 | |
| GeneFamily | Aldo-keto reductases | 6.86e-06 | 15 | 46 | 3 | 399 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.44e-04 | 18 | 46 | 2 | 91 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.10e-03 | 718 | 46 | 7 | 28 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.66e-05 | 395 | 61 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.69e-06 | 143 | 62 | 5 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 3.73e-06 | 168 | 62 | 5 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 4.30e-06 | 173 | 62 | 5 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 187 | 62 | 5 | 16e55d802fc4e71878305e61ad03806aabd59537 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.44e-06 | 188 | 62 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.44e-06 | 188 | 62 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-06 | 192 | 62 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-05 | 160 | 62 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-05 | 160 | 62 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 8.24e-05 | 165 | 62 | 4 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 8.84e-05 | 168 | 62 | 4 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.84e-05 | 168 | 62 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 9.04e-05 | 169 | 62 | 4 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 174 | 62 | 4 | 9f7b983459d47b12a1b64e17e29b85a6ff4dc258 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 174 | 62 | 4 | ba909e8789a62968e90bc1c4ab614de738c130f7 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 174 | 62 | 4 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 62 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 176 | 62 | 4 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 176 | 62 | 4 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 177 | 62 | 4 | 76f5df101c693e5fa61554244d877fc8169ee66f | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-04 | 178 | 62 | 4 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 1.15e-04 | 180 | 62 | 4 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 1.18e-04 | 181 | 62 | 4 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 182 | 62 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 182 | 62 | 4 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.25e-04 | 184 | 62 | 4 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 186 | 62 | 4 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.34e-04 | 187 | 62 | 4 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 188 | 62 | 4 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.39e-04 | 189 | 62 | 4 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.42e-04 | 190 | 62 | 4 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.45e-04 | 191 | 62 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 191 | 62 | 4 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.45e-04 | 191 | 62 | 4 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 192 | 62 | 4 | e44e37e5aeba8628556020d05e1606b28e2faa4f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.48e-04 | 192 | 62 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.48e-04 | 192 | 62 | 4 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 193 | 62 | 4 | 0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.54e-04 | 194 | 62 | 4 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.57e-04 | 195 | 62 | 4 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 196 | 62 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 196 | 62 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 196 | 62 | 4 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | mLN-T_cell-Treg|T_cell / Region, Cell class and subclass | 1.63e-04 | 197 | 62 | 4 | 3779489d57ebda33277c79cba037f4c73128c8ba | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.63e-04 | 197 | 62 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.66e-04 | 198 | 62 | 4 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 198 | 62 | 4 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.66e-04 | 198 | 62 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 198 | 62 | 4 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.66e-04 | 198 | 62 | 4 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 199 | 62 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 199 | 62 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 1.73e-04 | 200 | 62 | 4 | 3813fa1ee1462ba83fd8b6253070f46f0b063084 | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.11e-06 | 198 | 62 | 7 | 6259_DN | |
| Disease | Fetal Cerebral Ventriculomegaly | 8.77e-05 | 7 | 61 | 2 | C2936718 | |
| Disease | Cerebral ventriculomegaly | 8.77e-05 | 7 | 61 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 8.77e-05 | 7 | 61 | 2 | C0270720 | |
| Disease | Post-Traumatic Hydrocephalus | 8.77e-05 | 7 | 61 | 2 | C0477432 | |
| Disease | Communicating Hydrocephalus | 8.77e-05 | 7 | 61 | 2 | C0009451 | |
| Disease | Obstructive Hydrocephalus | 8.77e-05 | 7 | 61 | 2 | C0549423 | |
| Disease | Aqueductal Stenosis | 1.17e-04 | 8 | 61 | 2 | C2936786 | |
| Disease | Congenital Hydrocephalus | 1.17e-04 | 8 | 61 | 2 | C0020256 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 1.17e-04 | 8 | 61 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | Hydrocephalus | 1.50e-04 | 9 | 61 | 2 | C0020255 | |
| Disease | Respiratory Distress Syndrome, Adult | 2.04e-04 | 55 | 61 | 3 | C0035222 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 4.34e-04 | 15 | 61 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | Manic Disorder | 4.35e-04 | 71 | 61 | 3 | C0024713 | |
| Disease | TNF-related apoptosis-inducing ligand measurement | 4.53e-04 | 72 | 61 | 3 | EFO_0008300 | |
| Disease | Urticaria | 4.95e-04 | 16 | 61 | 2 | C0042109 | |
| Disease | Manic | 5.73e-04 | 78 | 61 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 5.94e-04 | 79 | 61 | 3 | C0005587 | |
| Disease | physical activity | 8.14e-04 | 88 | 61 | 3 | EFO_0003940 | |
| Disease | Nephritis, Interstitial | 1.13e-03 | 24 | 61 | 2 | C0027707 | |
| Disease | Liver Failure, Acute | 1.13e-03 | 24 | 61 | 2 | C0162557 | |
| Disease | Bell's palsy | 1.25e-03 | 102 | 61 | 3 | EFO_0007167 | |
| Disease | Nephrotic Syndrome | 1.43e-03 | 27 | 61 | 2 | C0027726 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.65e-03 | 29 | 61 | 2 | C1274933 | |
| Disease | Toxic Epidermal Necrolysis | 1.65e-03 | 29 | 61 | 2 | C0014518 | |
| Disease | Thrombocytopenia | 1.65e-03 | 29 | 61 | 2 | C0040034 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.65e-03 | 29 | 61 | 2 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.65e-03 | 29 | 61 | 2 | C3658302 | |
| Disease | Stevens-Johnson Syndrome | 1.76e-03 | 30 | 61 | 2 | C0038325 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1.76e-03 | 30 | 61 | 2 | C1868672 | |
| Disease | blood nickel measurement | 1.99e-03 | 120 | 61 | 3 | EFO_0007583 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKRYSLNEFCALKKN | 521 | Q9BXU7 | |
| YLNQSKLLDFCKSKD | 196 | P17516 | |
| SSAKQRLKCASLQKF | 216 | P02768 | |
| LCKLDYACKLASSDK | 191 | Q5JRM2 | |
| KRAACLVAAAYALKT | 21 | Q9UBJ2 | |
| LKFSKKDLSCSNFSL | 71 | O60242 | |
| YFNRSKLLDFCKSKD | 196 | P42330 | |
| KKRTTSAEKNTCQLY | 211 | O14672 | |
| EKNSKRDYLSSSFLC | 541 | Q96GX5 | |
| VAKFCYADKSLLNKA | 91 | P30038 | |
| CFQSLRRKNSKASKS | 421 | Q8WZ64 | |
| AKLNCRLYRKANKSS | 156 | P01008 | |
| ESAAAYTKATARKCL | 371 | Q9H6Z4 | |
| QLCQKLYSSKDTTKR | 246 | Q9BQ51 | |
| LKTSNSYLRKKAALC | 146 | O43747 | |
| SLLDTYQKCGLKRKS | 121 | Q9H2X6 | |
| KKTKDYVQDRSCNLA | 116 | Q8WXJ9 | |
| TDDCFANSKKYKTRR | 1631 | Q8IYD8 | |
| SYRDAKKKLRLALCS | 1116 | Q14C86 | |
| RKYKQAAKCLLLASF | 261 | Q13098 | |
| TSKADLNCSKNKDLY | 331 | Q5W0B1 | |
| SKKKLALCYTAACTN | 131 | P16581 | |
| RAKDCYSLALSKLEK | 851 | Q6UVM3 | |
| LLKSEKSSYQKCNSH | 261 | Q13772 | |
| AKYEDFLSCAKLLSK | 226 | Q8N264 | |
| LKDECKKLQSQYASS | 251 | Q15075 | |
| SLAKSCKSDLKKYRC | 371 | Q92896 | |
| LLCGKSRDKYKSSLF | 2831 | Q4G0P3 | |
| LLARYCDSLLKKSSK | 421 | Q13616 | |
| YSCTSKRKSKLADGE | 1021 | Q14CM0 | |
| SANRKCLHKSLYKKD | 161 | Q9NZ38 | |
| KKKSDANASYLRAAR | 36 | Q12955 | |
| KRSSTLDCKYKFESC | 221 | Q5SZL2 | |
| NSAAFKARTKARSKC | 426 | O00458 | |
| AKKLTNALSKSLSCA | 296 | Q9Y4J8 | |
| SKKNAQLEKRSFCSA | 846 | Q13002 | |
| SHKEDLANCYKSSLK | 156 | A1Z1Q3 | |
| CLGSLASKLSRKYVK | 151 | Q9Y2M0 | |
| RQCDKSFALKSYLHK | 271 | Q9NQ03 | |
| KLRNAFRCSSAKIKA | 36 | Q7LBE3 | |
| SLDKLECRFKLNSYK | 1161 | Q96ST3 | |
| DKKDKLRYLNSSRAS | 1756 | Q9UPS6 | |
| KDASSCYRQKKYALA | 181 | Q9BXB7 | |
| AKDAYLQSLAKKICS | 6 | O75683 | |
| KENLCNLEKKYSSLS | 801 | Q86SQ0 | |
| KEALKKLAYCQASRS | 296 | O95007 | |
| ETACRKSLKALKLNY | 81 | Q96JD6 | |
| KCYSDAAAKKQARSL | 346 | Q9Y446 | |
| KKLYDCKECASFSSL | 166 | Q8N8Z8 | |
| CESRQLSFSKKASKF | 186 | O75486 | |
| YKECNKRFLCSKALA | 1366 | Q13129 | |
| TKKNYKDLSNSESEC | 1021 | Q9BX26 | |
| DALSKYSECLKINNK | 641 | Q07617 | |
| SVKSAAKESLYCAQR | 776 | Q12772 | |
| KNNKSYVSKISSDCD | 441 | Q9HCK1 | |
| CSIKLDNSNSKKLTY | 471 | Q8NEG5 | |
| LSLNASNCKALYRKS | 116 | Q8IWR0 | |
| SNCKALYRKSKALSD | 121 | Q8IWR0 | |
| LYKCKECRKAFSQSS | 231 | B4DU55 | |
| CKLCSFKSSYNSRLK | 2056 | Q96JM2 | |
| QKSSSKAEYNLTACK | 346 | Q2TB10 | |
| YACAQSSKLNRHKKT | 266 | Q8WUU4 | |
| STYNCQLLKASSKKC | 276 | Q93070 |